Paid Clinical Trials in New Jersey

New Jersey has 1,726 paid clinical trials enrolling now across cities including New Brunswick, Middletown and Basking Ridge. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 4, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,560 clinical trials

Get a weekly email when new trials open in New Brunswick, NJ.

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

for Advanced or Metastatic Solid Tumor

Sites in East Brunswick +10 more locations

Sponsor: Pliant Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06270706·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

for Malignant Melanoma

Drug: Intismeran autogene

Sites in Hackensack +4 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06961006·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Hackensack +8 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT05981703·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery

for Hemostasis

Sites in Pennington +5 more locations

Sponsor: Ethicon, Inc.

Sex: All·Age: 22+

Code: NCT06664788·Recruiting·Listed Oct 2024

Apply to this trial

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

for Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)

Sites in New Brunswick +8 more locations

Sponsor: Arvinas Inc.

Sex: All·Age: 18+

Code: NCT06393738·Phase 1·Recruiting·Listed May 2024

Apply to this trial

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

for Myelodysplastic Syndromes

Sites in Hackensack +8 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT04419649·Phase 2·Recruiting·Listed Jun 2020

Apply to this trial

A Study of BG-C477 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Hackensack +8 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06596473·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients

for Paroxysmal Nocturnal Hemoglobinuria (PNH)

Drug: Iptacopan

Sites in New Brunswick +3 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 2 - 18

Code: NCT06934967·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Phagenyx® Registry Study

for Dysphagia

Sites in Neptune City +2 more locations

Sponsor: Phagenesis Ltd.

Sex: All·Age: All ages

Code: NCT06866418·Recruiting·Listed Mar 2025

Apply to this trial

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

for Squamous Non-small-cell Lung Cancer

Sites in Hackensack +7 more locations

Sponsor: Alentis Therapeutics AG

Sex: All·Age: 18+

Code: NCT06747585·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for Solid Tumors

Sites in Hackensack +2 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT05471856·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

Abbott Structural Heart Device Registry

for Heart Diseases

Sites in New Brunswick +12 more locations

Sponsor: Abbott Medical Devices

Sex: All·Age: All ages

Code: NCT06590467·Recruiting·Listed Sep 2024

Apply to this trial

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

for Advanced Solid Tumors

Drug: Calderasib

Sites in Hackensack +4 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT05067283·Phase 1·Recruiting·Listed Oct 2021

Apply to this trial

Busulfan Sample Collection Study

for Subjects Treated With Busulfan

1 location in New Brunswick

Sponsor: Saladax Biomedical, Inc.

Sex: All·Age: All ages

Code: NCT05711732·Recruiting·Listed Feb 2023

Apply to this trial

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

for Advanced Malignant Tumors

Sites in Hackensack +1 more location

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06764771·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

for Acute Gastrointestinal Bleeding

Sites in Piscataway +5 more locations

Sponsor: Medtronic - MITG

Sex: All·Age: 22+

Code: NCT06188585·Recruiting·Listed Jan 2024

Apply to this trial

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

for Advanced Solid Tumors

Sites in Morristown +2 more locations

Sponsor: Eikon Therapeutics

Sex: All·Age: 18+

Code: NCT07262619·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

for High-grade Serous Ovarian Carcinoma (HGSOC)

Sites in Hackensack +4 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06476808·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Integrity Implant System Post Market Clinical Follow-Up Study

for Rotator Cuff Tears of the Shoulder

Sites in Marlton +8 more locations

Sponsor: Anika Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06741527·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

for Multiple Myeloma in Relapse

Sites in Hackensack +7 more locations

Sponsor: Kelonia Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07075185·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for Gynecologic Cancers

Sites in Teaneck +7 more locations

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT07024784·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

for Overweight

Drug: Semaglutide

1 location in Secaucus

Sponsor: Shanghai World Leader Pharmaceutical Co., Ltd.

Sex: All·Age: 18 - 65

Code: NCT07465965·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study of ZW251 in Participants With Advanced Solid Tumors

for Hepatocellular Carcinoma

Sites in Hackensack +7 more locations

Sponsor: Zymeworks BC Inc.

Sex: All·Age: 18+

Code: NCT07164313·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for Solid Tumor

Sites in Hackensack +8 more locations

Sponsor: Sanofi

Sex: All·Age: 18+

Code: NCT05584670·Phase 1, Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

for Ventricular Ejection Fraction

Sites in Hackensack +7 more locations

Sponsor: Peerbridge Health, Inc

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06699056·Recruiting·Listed Nov 2024

Apply to this trial

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

for Cervical Squamous Cell Carcinoma

Sites in Hackensack +8 more locations

Sponsor: Alentis Therapeutics AG

Sex: All·Age: 18+

Code: NCT07169734·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

for Amyotrophic Lateral Sclerosis

Sites in Neptune City +3 more locations

Sponsor: Corcept Therapeutics

Sex: All·Age: 18+

Code: NCT05407324·Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection

for Age-Related (Dry) Macular Degeneration

1 location in Woodbridge

Sponsor: AI-Spectral

Sex: All·Age: 40+·Accepts healthy volunteers

Code: NCT07446582·Recruiting·Listed Mar 2026

Apply to this trial

CT-95 in Advanced Cancers Associated With Mesothelin Expression

for Mesothelin-Expressing Tumors

Sites in Hackensack +8 more locations

Sponsor: Context Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06756035·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

for Breast Cancer

Sites in Summit +1 more location

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT05950945·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

for Breast Neoplasms

Sites in New Brunswick +4 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06686394·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

for Hereditary Angioedemas

Sites in Belleville +4 more locations

Sponsor: CSL Behring

Sex: All·Age: 12+

Code: NCT07001280·Recruiting·Listed Jun 2025

Apply to this trial

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

for Healthy Volunteer Study

Sites in Marlton +2 more locations

Sponsor: Atea Pharmaceuticals, Inc.

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07314346·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

for Solid Tumors

Sites in New Brunswick +8 more locations

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT07123103·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

BioHealx® Anal Fistula Device Post Market Surveillance Study

for Fistula-in-ano

Sites in Hackensack +5 more locations

Sponsor: Signum Surgical USA Inc.

Sex: All·Age: 18 - 75

Code: NCT07021742·Recruiting·Listed Jun 2025

Apply to this trial

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for B-cell Non-Hodgkins Lymphoma (B-NHL)

Drug: Odronextamab

Sites in New Brunswick +8 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05685173·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Drug: Etentamig

Sites in New Brunswick +6 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06896916·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

Study to Evaluate CAY001 in Healthy Volunteers

for Healthy

1 location in Fair Lawn

Sponsor: Cayuga Biotech, Inc.

Sex: All·Age: 18 - 50·Accepts healthy volunteers

Code: NCT06845839·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

SynKIR-310 for Relapsed/Refractory B-NHL

for B Cell Lymphoma

Sites in New Brunswick +4 more locations

Sponsor: Verismo Therapeutics

Sex: All·Age: 18+

Code: NCT06544265·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

for Schizophrenia

Sites in Marlton +6 more locations

Sponsor: AbbVie

Sex: All·Age: 18 - 65

Code: NCT07145918·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial